drugset / Trial / NCT02862327

Intravenous Dexamethasone for Ropivacaine Axillary Block

NCT02862327

Phase 3 Completed 99 enrolled Centre Hospitalier Universitaire de Besancon
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Prospective monocentric double-blind controlled randomised trial Aim is to assess prolonged postsurgical analgesia by intravenous dexamethasone versus intravenous placebo, after ultrasound guided axillary brachial plexus block

Timeline

Start
2016-12-01
Primary completion
2017-03-16
Completion
2017-09-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 8 mg Intravenous
Comparator Ropivacaine Other / unclassified 0.475 % Other

Indications

No indication recorded.